Clinical Trials in Seattle

Showing 4541-4560 of 9,312 trials

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer

NCT03531632

The primary goal of this study is to characterize the safety, tolerability, and maximum tolerated dose (MTD) of MGD007 when combined with MGA012. Pharmacokinetics (PK), immunogenicity, pharmacodynamics (PD), and the anti-tumor activity of the combination of MGD007 and MGA012 will also be assessed.

Colorectal Cancer Metastatic

MacroGenics38 participantsStarted Jun 2018

New Haven, Connecticut, United States • Tampa, Florida, United States • Boston, Massachusetts, United States +3 more locations

COMPLETEDPhase 1/2< 1 mile

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

NCT01057121

This phase I/II trial studies the side effects and best dose of lenalidomide and to see how well it works in treating patients with acquired immunodeficiency syndrome (AIDS)-related Kaposi sarcoma (KS). Lenalidomide may stop the growth of tumor cells by blocking blood flow to the tumor.

National Cancer Institute (NCI)38 participantsStarted Aug 2010

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +10 more locations

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

Find Trials by Condition in Seattle

Genes Contributing to Hereditary Ovarian Cancer in Women and BRCA1/2 Wildtype Families

Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias

Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

A Multi-Center Trial to Study Acute Liver Failure in Adults

A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)

Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia

PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training

Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)

Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis

A Prospective Study to Assess the Utility of CA-4F in a Canadian Cardiology Setting

An Investigational Immuno-Therapy Study of Experimental Medication BMS-986178 by Itself or in Combination With Nivolumab and/or Ipilimumab in Participants With Solid Cancers That Are Advanced or Have Spread

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

Cook IVC Filter Study

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Argus® II Retinal Stimulation System Feasibility Protocol